Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The best shampoo formula used 1% high-weight hyaluronic acid, 10% acidic sophorolipid, and 1% salt for effective hair conditioning and cleansing without sulfates or silicones.

Tofacitinib is an effective and safe treatment for alopecia areata.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Topical immunotherapy with SADBE and DPCP is most effective for short-term hair regrowth in children with severe alopecia areata.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Albizia saponaria bark extract may help treat hair loss.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Anthralin cream helped 25% of patients with severe alopecia areata regrow hair, but caused skin irritation.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Upadacitinib improved multiple immune-related conditions in one patient.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

The combination therapy was effective and well-tolerated, especially in young patients.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The hydrogel with neem and tridax extracts effectively treats seborrheic dermatitis.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.